NCT03926702View on ClinicalTrials.gov

Tau Imaging With JNJ067

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

January 6, 2021

Study Completion Date

January 6, 2021

Conditions
Alzheimer DiseaseMild Cognitive ImpairmentProgressive Supranuclear Palsy
Interventions
DRUG

Radiopharmaceuticals

All subjects will receive radiopharmaceutical for positron-emission tomography (PET) scan.

Trial Locations (1)

94709

University of California, Berkeley, Berkeley

All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

University of California, Berkeley

OTHER

NCT03926702 - Tau Imaging With JNJ067 | Biotech Hunter | Biotech Hunter